NSCLC (NON-SMALL CELL LUNG CARCINOMA)
Clinical trials for NSCLC (NON-SMALL CELL LUNG CARCINOMA) explained in plain language.
Never miss a new study
Get alerted when new NSCLC (NON-SMALL CELL LUNG CARCINOMA) trials appear
Sign up with your email to follow new studies for NSCLC (NON-SMALL CELL LUNG CARCINOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lung cancer combo trial halted early after just 9 patients
Disease control TerminatedThis study tested whether adding the experimental drug itacitinib to standard chemotherapy (docetaxel) could help people with advanced non-small cell lung cancer live longer. The trial was designed for patients who had already tried one prior treatment. However, the study was sto…
Matched conditions: NSCLC (NON-SMALL CELL LUNG CARCINOMA)
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 26, 2026 12:09 UTC
-
Experimental lung cancer drug shows promise but trial halted early
Disease control TerminatedThis early-stage study tested a new drug, BG-60366, designed to break down a faulty protein (mutant EGFR) that drives growth in some lung cancers. The trial aimed to find a safe dose and see if the drug could shrink tumors in people with advanced non-small cell lung cancer that h…
Matched conditions: NSCLC (NON-SMALL CELL LUNG CARCINOMA)
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
Cancer drug combo trial halted early: what happened?
Disease control TerminatedThis early-phase study tested a combination of two drugs (atezolizumab and epacadostat) in 29 adults with advanced lung or bladder cancer that had already been treated with chemotherapy. The main goal was to check safety and find the right dose. The study was terminated early, so…
Matched conditions: NSCLC (NON-SMALL CELL LUNG CARCINOMA)
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 26, 2026 11:09 UTC